Hydrocodone Bitartrate And Homatropine Methylbromide Syrup label

Hydrocodone Bitartrate And Homatropine Methylbromide Syrup

Hydrocodone Bitartrate And Homatropine Methylbromide Syrup Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

Since drowsiness may, on occasion, occur with use of this drug, patients should be warned of this possibility and cautioned against driving a car or operating dangerous machinery.

Patients should avoid alcoholic beverages while taking this drug.

Due to its potential anticholinergic action, this drug should be used with caution in patients with asthma, glaucoma or enlargement of the prostate gland.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Meclizine Hydrochloride is contraindicated in individuals who have shown a previous hypersensitivity to it

History

There is currently no drug history available for this drug.

Other Information

Chemically, Meclizine HCl is 1-(p-chloro-α-phenylbenzyl)-4-(m-methylbenzyl) piperazine dihydrochloride monohydrate.

Meclizine HCI Tablets, USP are available in two different strengths: 12.5 mg and 25 mg. In addition each tablet contains the following inactive ingredients: Colloidal Silicon Dioxide, Croscarmellose Sodium, Lactose Monohydrate, Magnesium Stearate, Microcrystalline Cellulose. Also, Meclizine HCI Tablets USP, 12.5 mg contains FD&C Blue #1 Aluminum Lake (11-13%) and Meclizine HCI Tablets USP, 25 mg contains D&C Yellow #10 Aluminum Lake (15-20%).

Navigate to :

Hydrocodone Bitartrate And Homatropine Methylbromide Syrup Recall

Side Effects & Adverse Reactions

FDA Safety Alerts

Manufacturer Warnings

FDA Labeling Changes

Other Information

Trending Topics

Hydrocodone Bitartrate And Homatropine Methylbromide Syrup Manufacturers

Pharmaceutical Associates, Inc.
No Recall
Hydrocodone Bitartrate And Homatropine Methylbromide Syrup | Direct Rx
Motion Sickness
The initial dose of 25 to 50 mg of Meclizine HCI should be taken one hour prior to travel for protection against motion sickness. Thereafter, the dose may be repeated every 24 hours for the duration of the journey.
Rebel Distributors Corp
No Recall
Hydrocodone Bitartrate And Homatropine Methylbromide Syrup | Rebel Distributors Corp
Adults
One (1) teaspoonful (5 mL) of the syrup every 4 to 6 hours as needed; do not exceed six (6) teaspoonfuls in 24 hours.
Children 6 to 12 Years of Age
One-half (1/2) teaspoonful (2.5 mL) of the syrup every 4 to 6 hours as needed; do not exceed three (3) teaspoonfuls in 24 hours.
Physicians Total Care, Inc.
No Recall
Hydrocodone Bitartrate And Homatropine Methylbromide Syrup | Physicians Total Care, Inc.
Adults
One (1) teaspoonful (5 mL) of the syrup every 4 to 6 hours as needed; do not exceed six (6) teaspoonfuls in 24 hours.
Children 6 to 12 Years of Age
One-half (1/2) teaspoonful (2.5 mL) of the syrup every 4 to 6 hours as needed; do not exceed three (3) teaspoonfuls in 24 hours.
Morton Grove Pharmaceuticals, Inc.
No Recall
Hydrocodone Bitartrate And Homatropine Methylbromide Syrup | Morton Grove Pharmaceuticals, Inc.
Adults and children 12 years of age and over: 5 mL (teaspoonful) of the syrup every four to six hours as needed; do not exceed 6 teaspoonfuls in 24 hours.

Children 6 to 12 years of age: 2.5 mL (½ teaspoonful) of the syrup every four to six hours as needed; do not exceed 3 teaspoonfuls in 24 hours.
Hi-tech Pharmacal Co., Inc.
No Recall
Hydrocodone Bitartrate And Homatropine Methylbromide Syrup | Hi-tech Pharmacal Co., Inc.
Adults
One (1) teaspoonful (5 mL) of the syrup every 4 to 6 hours as needed; do not exceed six (6) teaspoonfuls in 24 hours.
Children 6 to 12 Years of Age
One-half (1/2) teaspoonful (2.5 mL) of the syrup every 4 to 6 hours as needed; do not exceed three (3) teaspoonfuls in 24 hours.